VA

Visakha Ankinapalli

Director DIN 02799740
DIN 02799740 First appointment Jun 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Visakha Ankinapalli

Data last updated:

Visakha Ankinapalli was a Director at Acro Therapeutics Private Limited (from 2014) and Director at Welink Smo India Private Limited (from 2010).

DIN 02799740
First Appointment 08 Jun 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acro Therapeutics Private Limited U85100TG2014PTC095649
Director11 Sep 20142014₹44.9 Lakh (FY 2017)Strike Off
Welink Smo India Private Limited U85100TG2010PTC068849
Director08 Jun 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Acro Therapeutics Private Limited
Welink Smo India Private Limited
Premium access

Shareholding and investment profile for Visakha Ankinapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Visakha Ankinapalli

Visakha Ankinapalli was first appointed on 08 Jun 2010 as Director at Welink Smo India Private Limited. The most recent appointment on record is 11 Sep 2014 at Acro Therapeutics Private Limited.

Visakha Ankinapalli held 2 earlier board appointments: Acro Therapeutics Private Limited (Director, from 11 Sep 2014); Welink Smo India Private Limited (Director, from 08 Jun 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available